> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on User Fee Programs’ Financial Efficiency
- URL: https://www.fdaweb.com/meeting-on-user-fee-programs-financial-efficiency/
- Published: 2021-05-19T12:00:00.000Z
- Updated: 2026-09-14T16:59:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149349

*Federal Register* notice: FDA has announced a 6/18 public meeting entitled “FDA Public Meeting on Financial Efficiency of Human Drug User Fee Programs.” The meeting will discuss financial transparency and efficiency of the Prescription Drug User Fee Act, the Biosimilar User Fee Act, and Generic Drug User Fee Amendments. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-05-19/pdf/2021-10566.pdf?ref=fdaweb.com).